Westhouse moves into regenerative medicine with Quy majority stake
This article was originally published in Clinica
Executive Summary
Westhouse Medical Services, a UK group of medical device and service companies, has acquired a 52% stake in regenerative medicine specialist Quy Biosciences. As well as giving Westhouse a foothold in this potentially lucrative market, the deal will aid the company's international expansion.